Cipla
BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | Pharmaceuticals
Quarterly Results of Cipla |
------------------- in Rs. Cr. ------------------- |
 |
|
|
Sep '08 |
Dec '08 |
Mar '09 |
Jun '09 |
Sep '09 |
|
| Sales Turnover |
1,354.69 |
1,341.99 |
1,366.74 |
1,376.04 |
1,442.88 |
| Other Income |
16.87 |
18.49 |
15.45 |
11.97 |
12.82 |
| Total Income |
1,371.56 |
1,360.48 |
1,382.19 |
1,388.01 |
1,455.70 |
| Total Expenses |
1,143.68 |
1,046.12 |
1,017.59 |
1,034.52 |
1,062.04 |
| Operating Profit |
211.01 |
295.87 |
349.15 |
341.52 |
380.84 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
227.88 |
314.36 |
364.60 |
353.49 |
393.66 |
| Interest |
5.59 |
11.02 |
13.27 |
10.47 |
8.36 |
| PBDT |
222.29 |
303.34 |
351.33 |
343.02 |
385.30 |
| Depreciation |
40.61 |
41.15 |
55.66 |
45.81 |
47.81 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
181.68 |
262.19 |
295.67 |
297.21 |
337.49 |
| Tax |
30.25 |
38.75 |
42.75 |
55.50 |
61.75 |
| Net Profit |
151.43 |
223.44 |
252.92 |
241.71 |
275.74 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
1.95 |
2.87 |
3.25 |
3.11 |
3.43 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
155.46 |
155.46 |
155.46 |
155.46 |
160.58 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
2.00 |
2.00 |
2.00 |
2.00 |
2.00 |
|
|
|
|
| Source : Religare Technova |
| Explore Cipla connections |
|
